Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
I have been studying virological matters for many years since I started to study hepatitis B virus research in Graduate School at Osaka University School of Medicine. I have learned a lot from Dr. Ken-ichi Matsubara and Dr. Toshiki Tsurimoto who were mentors at Graduate School, Dr. Koichi Yamanishi who had been Professor, Department of Microbiology at Osaka University School of Medicine, Dr. Norio Hayashi who had been Professor, Gastroenterology at Osaka University Graduate School of Medicine and Dr. Don Ganem who was a mentor when I was a postdoctoral fellow in his Lab at UCSF, through studying hepatitis B virus and Kaposi’s sarcoma-associated herpesvirus and still have been searching for how viruses regulate and/or modulate host cellular functions to maintain themselves.
I would like to clarify total processes how viruses enter into cells, express their genes, amplify the genomes, assemble virus particles and egress out of cells.Network
Dr. Glenn Simon Tillotson worked over 35 years in healthcare with almost 30 years in pharmaceuticals (R&D and Medical Affairs). He has completed his Bachelor of Science in Microbiology and Biochemistry from Liverpool Polytechnic, Liverpool, UK (1974-1978). In 1980 he received his Master of Science in Medicine from University of Manchester Medical School, Manchester, UK. Dr. Glenn Simon Tillotson was Visiting Distinguished Scientist of Public Health Research Institute in NYC (2001). In 2005, he has finished his Ph D from Richmond University, London. He worked as Fellow of Royal Society of Medicine, London, UK (2000), American College of Chest Physicians, Chicago (2006), International Society of Chemotherapy (2008) and Infectious Disease Society of America (2010). He received Alfred Soffer Award by American College of Chest Physicians for Editorial Excellence. Dr. Glenn Simon Tillotson has experience in drug research and development including pre-clinical studies, IND, NDA, MAA and product life cycle extension (sNDA). He had memberships of various societies. In 2014 and 2015, he worked as Scientific Advisory Board- Spero Pharmaceuticals, Cambridge MA and Scientific Advisory Board- Assembly BioSciences, NYC, respectively. Currently, Dr. Glenn Simon Tillotson working as Senior Vice President of Medical Affairs in Cempra Pharmaceuticals, Chapel Hill. He has demonstrated success in range of product development, product launches and life cycle management strategies, harnessed innovative communication strategies both externally and internally, developed several medical affairs teams both internationally and nationally and shown resourcefulness in business development activities. He served as Editorial Board and Reviewer for 24 different journals from 1991 to 2014). He has written 200 papers (>150 papers on PubMed), 5 book chapters. He edited e-book on Clostridium difficile, published in September 2013 by Future Medicine, London, UK. ? Given >500 lectures to National, Regional or State conferences.
Glenn S Tillotson has over 30 years pharmaceutical experience in pre-clinical and clinical research, commercialization, medical affairs, scientific communications including publication planning strategic drug development, life cycle management and global launch programs. He has been instrumental in the development and launch of ciprofloxacin, moxifloxacin, gemifloxacin, fidaxomicin and several other agents. He is a SVP of Medical Affairs where he is preparing for the launch of solithromycin for community acquired bacterial pneumonia.Network
Growing up under the chaotic Cultural Revolution in China, Dr. Bao has worked and lived in the U.S. for the past 14 years. She provides leadership and management for multi-million dollar international clinical research projects in the fields of HIV/AIDS and tuberculosis. She consults and advices in several international scientific communities in the areas of clinical trials, drug development, patient safety, and international regulations. Dr. Bao has given presentations and chaired workshops in international conferences in countries such as Ghana, South Africa, Israel, Brazil, Thailand, Singapore, Taiwan, England, France, Slovakia, Sweden, as well as many cities in China on the topics such as cancer research, infectious diseases, science administration, clinical trials, international partnerships, and global health initiatives. Dr. Bao spent the first part of her career as a physician treating pulmonary diseases patients. After becoming a Medical Director, Dr. Bao was selected to be the sole Chinese delegate to participate in an international health summit in Israel that was attended by health care leaders from 27 countries. The event shaped her vision in global health and provided her the opportunity to pursue a career tackling the global health issues. Prior to coming to the U.S., Dr. Bao earned a PhD from Weizmann Institute of Science from Israel under the supervision of Prof. Yosef Yarden. She has conducted breast cancer research and published significant discoveries in world leading journals. Dr. Bao has received many awards for her achievements in basic research, clinical work, and science administration from China, Israel, and the U.S. She has had over 30 articles published in peer reviewed journals. Dr. Bao was accepted by the SES Development Program Class 2016-2017 and will graduate in April 2017. The program is sponsored by the Asian American Government Executives Network with participation by the White House Initiative on Asian American and Pacific Islanders (WHIAAPI), the Office of Personnel Management (OPM), and the Equal Employment Opportunity Commission (EEOC). Currently Dr. Bao serves as the Chair of the Washington DC Chapter of the American Woman for International Understanding. She is also the Program Chair of the NIH Chapter of the Federal Asian Pacific American Council and a member of the Asian American Government Executives Network. Dr. Bao’s personal journey, from a Medical Director in China to a cancer researcher in Israel to overseeing government sponsored international projects in the United States has exposed her to both the benefits of diversity and to the obstacles that must be overcome. She appreciates the entire spectrum of challenges and opportunities as an immigrant. She also has a passion to improve global health and cross-culture communication and has published many articles, essays, and two books addressing these issues.
Dr. Bao provides leadership and management for multi-million dollar international clinical research projects in the fields of HIV/AIDS and tuberculosis. She consults and advices in several international scientific communities in the areas of clinical trials, drug development, patient safety, and international regulations.Network
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals